How many institutions held BHC - Bausch Health Companies Inc. - Common Shares, No Par Value in Q1 2020?

290 institutional investors reported BHC - Bausch Health Companies Inc. - Common Shares, No Par Value for Q1 2020. Use the holders table for investor-level position and value details.

Bausch Health Companies Inc. - Common Shares, No Par Value (BHC)

Q: What does CUSIP 071734107 represent in this 13F holders report?

CUSIP 071734107 is the security identifier for BHC - Bausch Health Companies Inc. - Common Shares, No Par Value used to aggregate holder disclosures.

CUSIP: 071734107

Q1 2020 13F Holders as of 31 Mar 2020

Security type / class: Equity / Common Shares, No Par Value
Total 13F shares: 241,435,950
Total 13F value: $3,730,814,857
Share change: +23,199,458
Put/Call ratio: 147%
SEC-reported price per share: $15.50
Number of holders: 290
Value change: +$236,661,430
Number of buys: 139
Number of sells: 171
Shares outstanding: 374,002,024

Security key

071734107

Report period

Q1 2020

Institutions

290

Top holders

BHC full security history Ownership snapshot Full 13F holder table Bausch Health Companies Inc. SEC filings Bausch Health Companies Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BHC - Bausch Health Companies Inc. - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

FIL Ltd

Disclosed value leader

FIL Ltd

Comparable rows

15/15

Latest evidence

31 Dec 2019

13F Lead comparable stake: 7.2% Showing 1-6 of 15 holder rows.

Quick read

FIL Ltd leads the comparable SEC ownership view at 7.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FIL Ltd's linked filing trail.

Comparable ownership Top 5

FIL Ltd 7.2%

PAULSON & CO. INC. 5.6%

ValueAct Holdings, L.P. 4.8%

GLENVIEW CAPITAL MANAGEMENT, LLC 4.4%

RENAISSANCE TECHNOLOGIES LLC 3.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
FIL Ltd	13F Company 13F	7.2%	$806,592,000 26,947,455 shares	—	31 Dec 2019
PAULSON & CO. INC.	13F Company 13F	5.6%	$623,504,000 20,839,035 shares	—	31 Dec 2019
ValueAct Holdings, L.P.	13F Company 13F	4.8%	$536,513,000 17,931,594 shares	—	31 Dec 2019
GLENVIEW CAPITAL MANAGEMENT, LLC	13F Company 13F	4.4%	$497,181,000 16,617,008 shares	—	31 Dec 2019
RENAISSANCE TECHNOLOGIES LLC	13F Company 13F	3.3%	$373,769,000 12,491,799 shares	—	31 Dec 2019
VANGUARD GROUP INC	13F Company 13F	2.6%	$292,279,000 9,768,661 shares	—	31 Dec 2019

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

290

241,435,950

Rows available

290

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2020 vs Q1 2020 Across Filers

Q1 2020 holders

290

Q1 2020 holders

290

Holder diff

Investor	Q1 2020 Shares	Q1 2020 Shares	Share Diff	Share Chg %	Q1 2020 value	Q1 2020 value	Value change	Value Chg %